Albany, NY -- (SBWIRE) -- 04/12/2016 -- A new market research study by Transparency Market Research provides a thorough analysis of the global market for CEA antibodies, emphasizing on the major drivers and barriers, key products and segmentation, major geographical segments, current trends, and competitive scenario. The research study, titled "CEA Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023," has also included historical statistics and estimate figures with the help of infographics, charts, tables, and graphs.

CEA refers to carcinoembryonic antigen, which is a protein that is commonly produced in developing fetuses and is mostly absent in adults. The production of an abnormal quantity of CEA protein is expected to result in cancer. A CEA test is widely performed in order to measure the protein's levels and check for the occurrence of colon and other types of cancers in patients who are already diagnosed with cancer. Elevated levels of CEA indicate various kinds of cancers and other conditions, including lung infections, cholecystitis, inflammatory bowel diseases, heavy smoking, and peptic ulcers.

The global market for CEA antibodies has been categorized on the basis of geography into North America, Europe, Latin America, Asia Pacific, and Rest of the World. In 2012, the North America market held the largest share in the overall CEA antibodies market, owing to the presence of a vast number of companies involved in manufacturing and developing CEA antibodies. In addition, the increasing research and development expenditure by major players in North America is estimated to fuel the growth of the market in the next few years. Moreover, growing government initiatives associated with the development of CEA antibodies will further augment the growth of the CEA antibody market in this region.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4682

North America is followed by Europe, which held the second largest position in the overall market in 2012. The substantial growth of this region can be attributed to the increasing geriatric population and the rising healthcare expenditure in this region. Asia Pacific and Rest of the World accounted for a small share in the global CEA antibodies market due to the presence of very few pharmaceutical companies active in the field and lack of awareness among the population.

The research study on the global market for CEA antibodies further analyzes the competitive scenario and vendor analysis of the market. A thorough analysis of the major players has been included in the study, focusing on their profiles, inception details, contact information, financial overview, SWOT analysis, business strategies, products offered, and major developments in the market. Some of the major players operating in the global market for CEA antibodies are Danaher Corporation (Beckman Coulter), Abbott Laboratories, bioMerieux, Life Technologies Corporation, Qiagen N.V., Myriad Genetics, Epigenomics, and Siemens Healthcare.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/